Indication

Bladder hyperactivity

Bladder hyperactivity, clinically termed overactive bladder or detrusor overactivity, is a lower urinary tract disorder characterized by involuntary contractions of the detrusor smooth muscle during the bladder-filling phase. Read more about Bladder hyperactivity

205 drugs 101 manufacturers

Advertisement

Drugs that treat it

Common Bladder hyperactivity therapies.

Showing 82–90 of 205 drugs

Filter & compare in the drug finder →Opens the drug finder with Bladder hyperactivity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bladder hyperactivity.

Bladder hyperactivity, clinically termed overactive bladder or detrusor overactivity, is a lower urinary tract disorder characterized by involuntary contractions of the detrusor smooth muscle during the bladder-filling phase.

It affects adult populations across both sexes, with prevalence rising markedly with advanced age, metabolic dysfunction, or underlying neurologic disease.

Pathophysiologically, the condition stems from neurogenic dysregulation, myogenic hypersensitivity, or altered urothelial afferent signaling, which trigger inappropriate neuromuscular stimulation.

Clinically, it manifests as urinary urgency—often accompanied by increased daytime frequency and nocturia—occurring with or without urge urinary incontinence in the absence of a urinary tract infection or other identifiable local pathology.

Personalize your experience

Follow Bladder hyperactivity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it